Evaluation of FM220 in Patients With Peripheral Arterial Disease (PAD)

  • STATUS
    Recruiting
  • participants needed
    90
  • sponsor
    FlowMedic
Updated on 22 January 2022
arteriopathy
antiplatelet therapy
statin
vascular disease
intermittent claudication
cilostazol
exercise ankle

Summary

The purpose of this study is to determine whether 12 weeks of daily home use of the FM220 in the most affected leg of patients with PAD and claudication, will improve peak walking time (PWT) at three months as compared with a non-treated control group.

Details
Condition Peripheral Arterial Disease, Intermittent Claudication
Treatment Intermittent compression
Clinical Study IdentifierNCT00146666
SponsorFlowMedic
Last Modified on22 January 2022

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note